REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Five-membered Hetero Ring Containing At Least One Nitrogen Ring Atom (e.g., 1,2,3-triazoles, Etc.) > 1,3,4-thiadiazoles (including Hydrogenated) > Chalcogen Bonded Directly To Ring Carbon Of The Oxazole Ring Chalcogen Bonded Directly To Ring Carbon Of The Oxazole RingChalcogen Bonded Directly To Ring Carbon Of The Oxazole Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/16/06 - 20060258724 - Substituted oxazolidinones and their use in the field of blood coagulation processes for their preparation and their use as medicinally active compounds for the prophylaxis and/or treatment of disorders are described. ... 11/09/06 - 20060252809 - N-thiolated 2 oxazolidone antibiotics This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class of anti bacterial agents. These compounds can be synthesized from 2-oxazolidinones by Ndeprotection and N-sulfenylation. These new substances were found to exhibit potent anti-bacterial activity, including bacteriostatic properties against Staphylococcus spp., including methicillin resistant Staphylcoccus aureus ... 11/02/06 - 20060247286 - Oxazolidinone antibiotics and derivatives thereof its enantiomer, diastereomer, or pharmaceutically acceptable salt or ester thereof. ... 10/26/06 - 20060241160 - Zolmitriptan crystal forms The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A. ... 10/26/06 - 20060241159 - Zolmitriptan crystal forms The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A. ... 10/26/06 - 20060241158 - Zolmitriptan crystal forms The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A. ... 10/12/06 - 20060229349 - 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents or a pharmaceutically acceptable salt thereof wherein R1 is C1-4alkyl, optionally substituted with a fluoro atom, or R1 is a cyclopropyl or cyclopropylmethyl; and R2 is methyl or ethyl. These compounds are useful as antibacterial agents. ... 10/12/06 - 20060229348 - Oxindole oxazolidinone as antibacterial agent or a pharmaceutically acceptable salt thereof wherein R1 is C1-4alkyl, optionally substituted with a fluoro atom, or R1 is a cyclopropyl or cyclopropylmethyl; and R2 is methyl or ethyl. The compound is useful as antibacterial agents. ... 09/21/06 - 20060211751 - Zolmitriptan crystal forms The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A. ... 09/14/06 - 20060205799 - Anti-cancer and anti-microbial oxazolidinones Disclosed herein are various novel oxazolidinone, imidazolidinone, and thiazolidinone analogs and methods of treating cancer and/or microbial infection using these analogs. Particular 4-oxazolidinone compounds are shown to have anti-cancer and anti-microbial activity. ... 07/27/06 - 20060167069 - Pharmaceutical composition of metaxalone with enhanced oral bioavailability The present invention provides a pharmaceutical composition comprising metaxalone and pharmaceutically acceptable excipients, characterized in that the pharmaceutical composition has enhanced oral bioavailability. The present invention also provides a pharmaceutical composition comprising metaxalone and pharmaceutically acceptable excipients, characterized in that the extent of absorption of metaxalone is independent of whether ... 07/06/06 - 20060148869 - Halogenated biaryl heterocyclic compounds and methods of making and using the same The present invention relates generally to the field of anti-infective anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of compounds having at least one halogenated hydrocarbon moiety, a biaryl moiety, and at least one heterocyclic moiety, that are useful as such agents. ... 07/06/06 - 20060148868 - Zolmitriptan polymorphs Crystalline polymorphic forms of zolmitriptan, solid amorphous zolmitriptan, and processes for preparing them. ... 06/22/06 - 20060135579 - Compositions that bind antiterminator rna and assay for screening for such compositions Compounds that are selective binding agents specific for RNA secondary and tertiary structures and a fluorescence assay for detecting the binding of small molecules to T-box antiterminator model mRNAs. The compounds include novel tri-substituted oxazolidinones and amino alcohols. The assay provides fluorescently labeled model mRNAs that include conserved sequence information ... 02/23/06 - 20060040999 - Cetp inhibitors In the compounds of Formula I, B or R2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring ... 02/09/06 - 20060030609 - Oxazolidinones containing oxindoles as antibacterial agents R2 is —H or —CH3. These compounds are useful as antibacterial agents. ... 11/03/05 - 20050245585 - Process for preparing optically pure zolmitriptan A process for preparing zolmitriptan, proceeding through the intermediate Ethyl-3-[2-(1,3-dioxo-2,3-dihydro-1H-2-isoindoleyl)ethyl]-5-[(4S)-2-oxo-1,3-oxazolan-4-ylmethyl]-1H-2-indole carboxylate. ... 10/13/05 - 20050228033 - Novel sodium channel blockers The present invention is directed to novel phenytoin derivative compounds and the use of such compounds as sodium channel blockers. Such compositions have utility as anti-cancer agents and can be used to limit or prevent PCa growth and/or metastasis. ... 10/06/05 - 20050222229 - Fungicidal mixtures in a synergistically effective amount, methods for controlling harmful fungi using mixtures of the compounds I and II and the use of the compounds I and II for preparing such mixtures are described. ... 09/01/05 - 20050192325 - Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues or pharmaceutically acceptable salts or prodrugs thereof that are antibacterial agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds. ... 08/25/05 - 20050187274 - One pot synthesis of 2-oxazolidinone derivatives The present invention provides an improved process for preparing (S)-4{[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl}-2-oxazolidinone which comprises: a) forming a carbamate of formula (III), from methyl 4-nitro-(L)-phenylalaninate hydrochloride; b) reducing the compound of formula (III) to give the compound of formula (IV); c) reducing the methyl ester grouping in the compound of formula (IV) to ... 08/18/05 - 20050182112 - Chemical compounds wherein m is 0, 1 or 2; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described. ... 08/04/05 - 20050171170 - Clean, high-yield preparation of s,s and r,s amino acid isosteres The present invention provides compounds and methods that can be used to convert the intermmediate halomethyl ketones (HMKs), e.g., chloromethyl ketones, to the corresponding S,S- and R,S-diastereomers. More particularly, the present invention provides: (1) reduction methods; (2) inversion methods; and (3) methods involving the epoxidation of alkenes. Using the various ... ### FreshPatents.com Support |